Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SELLAS Life Sciences Group, Inc. - Common Stock (NQ:SLS)

2.840 +0.070 (+2.53%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about SELLAS Life Sciences Group, Inc. - Common Stock

News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Nasdaq Tumbles 2%; Timber Pharmaceuticals Shares Spike Higher ↗
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 450 points on Friday. The Dow traded down 1.39% to 32,692.94 while the NASDAQ fell 2.14% to 11,342.36. The S&P 500 also... 
Via Benzinga
News headline image
US Stocks Open Lower; Dow Drops 1% ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Friday. Following the market opening Friday, the Dow traded down 1.05% to 32,807.33 while the NASDAQ fell 1.52% to... 
Via Benzinga
News headline image
PIXY Stock Alert: What to Know as ShiftPixy Utilizes ChatGPT for Recruiting ↗
ShiftPixy (PIXY) stock is on the move Friday after the company announced plans to use ChatGPT for recruiting and hiring. 
Via InvestorPlace
News headline image
Why Sellas Life Sciences Shares Are Nosediving ↗
Sellas Life Sciences Group Inc (NASDAQ: SLS) shares are trading lower by 52.57% to $1.75 Friday morning after the company announced pricing of a $20 million underwritten public offering. What Else? 
Via Benzinga
News headline image
BA Stock Alert: Boeing Halts Deliveries of 787 Dreamliners ↗
Boeing (BA) stock is a hot topic among traders on Friday after the aerospace company halted deliveries of its 787 Dreamliner. 
Via InvestorPlace
News headline image
Why Is Nektar Therapeutics (NKTR) Stock Down 39% Today? ↗
Nektar Therapeutics (NKTR) stock is taking a beating on Friday following the release of poor Phase 2 clinical trial data. 
Via InvestorPlace
News headline image
Why Is SELLAS Life Sciences (SLS) Stock Down 38% Today? ↗
SELLAS Life Sciences (SLS) stock is falling on Friday after the biopharmaceutical company announced a proposed public offering. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
It's time to start off trading on Friday with a breakdown of the biggest pre-market stock movers worth keeping an eye on! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
SELLAS Life Sciences Highlights Data From Early Study In Blood Cancer Patients ↗
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Looking Into SELLAS Life Sciences Gr's Recent Short Interest ↗
SELLAS Life Sciences Gr's (NASDAQ:SLS) short percent of float has risen 15.26% since its last report. The company recently reported that it has 1.15 million shares sold short, which is 5.59% of all... 
Via Benzinga
News headline image
Dow Surges 150 Points; Crude Oil Falls Sharply ↗
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday. 
Via Benzinga
News headline image
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday ↗
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus... 
Via Benzinga
News headline image
SELLAS Life Sciences Shares Tumble As Acute Myeloid Leukemia Trial Will Longer Than Anticipated ↗
 
Via Benzinga
News headline image
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
Silver Rises Over 1%; Tyson Foods Posts Downbeat Earnings ↗
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping around 60 points on Monday. 
Via Benzinga
News headline image
US Stocks Mostly Lower; Nasdaq Drops Over 100 Points ↗
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Monday. 
Via Benzinga
News headline image
SELLAS Life Sciences' GPS Combo Therapy Shows Overall Survival Of 18 Months In Pretreated Ovarian Cancer Patients ↗
 
Via Benzinga
News headline image
Why FAT Brands Shares Are Trading Sharply Lower; Here Are 24 Stocks Moving Premarket ↗
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares rose 39.5% to $24.39 in pre-market trading following recent reports that Donald Trump could soon announce 2024 Presidential run. 
Via Benzinga
News headline image
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Adamis Pharmaceuticals (NASDAQ:ADMP) shares moved upwards by 28.1% to $0.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $28.1 million. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
It's time for another dive into the biggest pre-market stock movers as we check out what's behind shares moving on Wednesday! 
Via InvestorPlace
News headline image
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday ↗
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. 
Via Benzinga
News headline image
SELLAS Life Sciences Touts Encouraging Preclinical Data For Candidate For Aggressive Form Of Prostate Cancer ↗
 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.